E. Emberley

发表

Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis

L. Murphy, P. Watson, A. Civetta, 2005, BMC Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.

L. Murphy, P. Watson, E. Kliewer, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

S100A7 and the progression of breast cancer

L. Murphy, P. Watson, E. Emberley, 2004, Breast Cancer Research.

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Weiqun Li, Melissa G. Works, P. Murray, 2017, Journal of Immunotherapy for Cancer.

Estrogen receptor-β regulates psoriasin (S100A7) in human breast cancer

L. Murphy, P. Watson, J. Davie, 2007, Breast Cancer Research and Treatment.

S100 proteins and their influence on pro-survival pathways in cancer.

L. Murphy, P. Watson, E. Emberley, 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer

L. Murphy, P. Watson, R. D. Gietz, 2002, BMC Cancer.

Psoriasin (S100A7) expression is altered during skin tumorigenesis

P. Watson, E. Emberley, S. Alowami, 2003, BMC dermatology.

The Role of S100A7/RANBPM Interaction in Human Breast Cancer

P. Watson, E. Emberley, 2001 .

Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity.

Clarissa C. Lee, Weiqun Li, M. V. Van Zandt, 2022, Journal of medicinal chemistry.

Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer

D. Absher, D. Rakheja, S. Ogawa, 2018, Clinical Cancer Research.

Identification of new human coding steroid receptor RNA activator isoforms.

L. Murphy, P. Watson, E. Leygue, 2003, Biochemical and biophysical research communications.

Reciprocal negative regulation between S100A7/psoriasin and β-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity

P. Watson, John Calvin Reed, S. Matsuzawa, 2008, Oncogene.

Analysis of gene expression in ductal carcinoma in situ of the breast.

A. Harris, L. Murphy, P. Watson, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.

Saman Sadeghi, David B Shackelford, Johannes Czernin, 2017, Cell reports.

Deconjugation of Nedd8 from Cul1 Is Directly Regulated by Skp1-F-box and Substrate, and the COP9 Signalosome Inhibits Deneddylated SCF by a Noncatalytic Mechanism

Raymond J. Deshaies, R. Deshaies, Ethan D. Emberley, 2012, The Journal of Biological Chemistry.

Control of cullin-ring ubiquitin ligase activity by nedd8.

Anjanabha Saha, R. Deshaies, E. Emberley, 2010, Sub-cellular biochemistry.

The steroid receptor RNA activator is the first functional RNA encoding a protein

P H Watson, P. Watson, E. Leygue, 2004, FEBS letters.

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.

L. Murphy, P. Watson, S. Gibson, 2005, Cancer research.

Psoriasin interacts with Jab1 and influences breast cancer progression.

L. Murphy, P. Watson, R. D. Gietz, 2003, Cancer research.

Psoriasin Interacts with Jab 1 and Influences Breast Cancer Progression 1

L. Murphy, P. Watson, R. D. Gietz, 2003 .

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast

L. Murphy, P. Watson, E. Emberley, 2004, Breast Cancer Research.

Review S100A7 and the progression of breast cancer

L. Murphy, P. Watson, E. Emberley, 2004 .

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.

P. Watson, P. Johnston, Peter H. Watson, 2005, Cancer research.

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma

Weiqun Li, F. Parlati, Tony T. Huang, 2021, PloS one.

Necrosis and Hypoxia in Invasive Breast Carcinoma

A. Harris, P. Watson, J. Pastorek, 2003, Breast Cancer Research and Treatment.

Analysis of Gene Expression in Ductal Carcinoma in Situ of the Breast 1

A. Harris, L. Murphy, P. Watson, 2002 .

CB-839, a selective glutaminase inhibitor, has anti-tumor activity in renal cell carcinoma and synergizes with everolimus and receptor tyrosine kinase inhibitors

Weiqun Li, M. Bennett, F. Parlati, 2016 .

Abstract 4134: Reversal of adenosine-mediated immune suppression by CB-708, an orally bioavailable and potent small molecule inhibitor of CD73

Clarissa C. Lee, Weiqun Li, F. Parlati, 2019, Immunology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.